Lycia Therapeutics Files for Nasdaq IPO, Offering 17.64 Million Shares
Lycia Therapeutics is offering 17,640,000 common shares at $18.00 each. The shares are expected to trade on the Nasdaq Global Select Market under ticker LYCA.
Lycia Therapeutics is offering 17,640,000 common shares at $18.00 each. The shares are expected to trade on the Nasdaq Global Select Market under ticker LYCA.